|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.800 SEK | +6.02% |
|
+2.44% | -34.81% |
| 07-07 | Vivesto chairman Peter Zonabend increases his shareholding | FW |
| 07-01 | Vivesto Completes Enrollment in Cat Study of Paccal Vet | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIVESTO AB | Other Pharmaceuticals | +6.02% | +2.44% | -34.81% | -62.39% | -97.10% | 9.54M |  |  | |
- Stock Market
- Stocks
- VIVE Stock
- Charts Vivesto AB
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
